Syai Tag continuous glucose monitoring for ICU patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers at University Medical Centre Maribor will enroll at least 100 adult intensive care patients who require blood sugar monitoring and have an arterial line. Each participant will wear two small Syai Tag sensors on the upper arms that continuously record glucose while clinical teams perform routine arterial blood glucose measurements; the sensor readings will be hidden from staff. The study will compare paired sensor and arterial blood results to determine accuracy and will track any device-related safety issues. Patients under 18, pregnant individuals, or those with skin conditions preventing sensor placement will be excluded.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Admission to the intensive care unit
* Expected ICU stay more than 24 hours
* Presence of an arterial line

Exclusion Criteria:

* Age under 18
* Pregnancy
* Skin changes that prevent sensor application

Where it's running

• UMC Maribor
  Maribor, Slovenia Recruiting

Study contacts

• Principal investigator: Nika Kravos Tramšek, MD PhD — UMC Maribor
• Study coordinator: Nika Kravos Tramšek, MD PhD
• Email: nikakravos@gmail.com
• Phone: +38631423030

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using blood tests to identify bacteria in ICU patients with sepsis

  This study is testing a new blood test to see if it can help doctors find harmful bacteria in ICU patients with sepsis so they can better track infections and improve patient care.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan · NCT06791889

• Ruta C and Vitamin C in Sepsis: Adding antioxidants to standard care

  This trial tests whether adding Ruta C (rutin plus vitamin C) or vitamin C alone to standard sepsis treatment helps adults in the ICU stay shorter and recover better.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07922213

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• Neutrophil EMR3 as a biomarker for sepsis in ICU patients

  Researchers will test whether measuring EMR3 on neutrophils helps diagnose sepsis, monitor progression, and predict outcomes in adults in Chinese ICUs.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang · NCT07896018

• Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing

  A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.

  Recruiting Second Affiliated Hospital of Nanchang University · Nanchang, Jang XI · NCT07881588

• Thymalfasin added to standard care for adults with sepsis and immune dysfunction

  This study tests whether thymosin alpha-1 helps restore immune function in adults with sepsis who have weakened immunity.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07866118

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.